Security
Phibro Animal Health Corporation Class A Common Stock · PAHC
PAHCNASDAQCommon stockCurrentCIK 1069899Updated Nov 6, 2026
Name history
PHILIPP BROTHERS CHEMICALS INC · through May 14, 2003
PAHC price & chart
Loading TradingView…
NASDAQ:PAHC on TradingView ↗About the company
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com.
In the news
No coverage from other publishers is available.
Recent filings
Results of Operations and Financial Condition · Submission of Matters to a Vote of Security Holders
Items 2.02, 5.07, 9.01
10-Q filing
Other Events
Items 8.01, 9.01
ARS filing
DEFA14A filing
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,445,118,000Source | 1,317,260,000Source | 979,035,000Source | 1,405,553,000Source | 1,285,509,000Source | 972,708,000Source | 1,385,524,000Source | 966,289,000Source | 1,501,241,000Source | 1,360,900,000Source | 982,184,000Source | 971,397,000Source |
| Property, Plant and Equipment, NetUSD | 359,271,000Source | 336,093,000Source | 202,061,000Source | 355,381,000Source | 337,662,000Source | 200,839,000Source | 354,780,000Source | 206,315,000Source | 369,174,000Source | 354,690,000Source | 203,300,000Source | 195,568,000Source |
| GoodwillUSD | 59,889,000Source | 54,570,000Source | 54,644,000Source | 59,814,000Source | 54,549,000Source | 54,683,000Source | 59,708,000Source | 54,588,000Source | 60,045,000Source | 59,645,000Source | 54,557,000Source | 53,274,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 54,929,000Source | 60,354,000Source | 50,225,000Source | 55,486,000Source | 67,074,000Source | 32,970,000Source | 72,769,000Source | 51,837,000Source | 61,419,000Source | 68,039,000Source | 70,613,000Source | 41,281,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 221,546,000Source | 197,518,000Source | 161,087,000Source | 215,872,000Source | 191,789,000Source | 150,627,000Source | 217,896,000Source | 160,777,000Source | 238,794,000Source | 227,983,000Source | 169,452,000Source | 163,479,000Source |
| Inventory, NetUSD | 539,699,000Source | 448,390,000Source | 282,289,000Source | 517,347,000Source | 427,224,000Source | 286,680,000Source | 471,775,000Source | 272,556,000Source | 534,883,000Source | 444,425,000Source | 265,911,000Source | 277,570,000Source |
| Assets, CurrentUSD | 894,068,000Source | 776,018,000Source | 597,180,000Source | 862,185,000Source | 746,153,000Source | 586,586,000Source | 835,799,000Source | 570,767,000Source | 935,506,000Source | 810,606,000Source | 600,997,000Source | 585,723,000Source |
| Operating Lease, Right-of-Use AssetUSD | 49,237,000Source | 42,239,000Source | 37,100,000Source | 39,416,000Source | 37,359,000Source | 38,159,000Source | 40,146,000Source | 37,559,000Source | 51,574,000Source | 41,339,000Source | 37,604,000Source | 35,759,000Source |
| Other Assets, NoncurrentUSD | 100,205,000Source | 112,813,000Source | 76,911,000Source | 95,107,000Source | 107,251,000Source | 79,638,000Source | 100,273,000Source | 91,684,000Source | 106,464,000Source | 99,490,000Source | 78,297,000Source | 81,845,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,083,291,000Source | 1,051,268,000Source | 708,941,000Source | 1,073,192,000Source | 1,038,707,000Source | 701,905,000Source | 1,073,843,000Source | 707,762,000Source | 1,115,764,000Source | 1,075,218,000Source | 725,543,000Source | 688,888,000Source |
| Stockholders’ equity: | ||||||||||||
| Retained Earnings (Accumulated Deficit)USD | 336,115,000Source | 260,341,000Source | 247,995,000Source | 316,959,000Source | 244,326,000Source | 244,450,000Source | 294,364,000Source | 246,001,000Source | 352,958,000Source | 272,701,000Source | 243,886,000Source | 260,912,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -112,471,000Source | -131,169,000Source | -114,004,000Source | -122,370,000Source | -134,165,000Source | -109,615,000Source | -120,021,000Source | -123,935,000Source | -106,077,000Source | -124,018,000Source | -123,527,000Source | -114,210,000Source |
| Stockholders' Equity Attributable to ParentUSD | 361,827,000Source | 265,992,000Source | 270,094,000Source | 332,361,000Source | 246,802,000Source | 270,803,000Source | 311,681,000Source | 258,527,000Source | 385,477,000Source | 285,682,000Source | 256,641,000Source | 282,509,000Source |
| Additional Paid in Capital, Common StockUSD | 138,179,000Source | 136,816,000Source | 136,099,000Source | 137,768,000Source | 136,637,000Source | 135,964,000Source | 137,334,000Source | 136,457,000Source | 138,592,000Source | 136,995,000Source | 136,278,000Source | 135,803,000Source |
| Liabilities and EquityUSD | 1,445,118,000Source | 1,317,260,000Source | 979,035,000Source | 1,405,553,000Source | 1,285,509,000Source | 972,708,000Source | 1,385,524,000Source | 966,289,000Source | 1,501,241,000Source | 1,360,900,000Source | 982,184,000Source | 971,397,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 281,870,000Source | 266,481,000Source | 189,072,000Source | 282,370,000Source | 233,250,000Source | 187,735,000Source | 270,139,000Source | 176,894,000Source | 316,468,000Source | 293,473,000Source | 204,148,000Source | 176,000,000Source |
| Operating Lease, Liability, CurrentUSD | 9,419,000Source | 8,988,000Source | 7,107,000Source | 8,959,000Source | 8,019,000Source | 7,003,000Source | 9,021,000Source | 7,897,000Source | 10,572,000Source | 9,127,000Source | 7,460,000Source | 6,053,000Source |
| Accounts Payable, CurrentUSD | 129,643,000Source | 131,622,000Source | 82,613,000Source | 133,296,000Source | 99,445,000Source | 86,410,000Source | 130,597,000Source | 86,528,000Source | 127,314,000Source | 138,201,000Source | 85,567,000Source | 73,853,000Source |
| Operating Lease, Liability, NoncurrentUSD | 42,509,000Source | 33,626,000Source | 30,062,000Source | 32,968,000Source | 28,315,000Source | 31,193,000Source | 33,116,000Source | 29,819,000Source | 45,401,000Source | 33,740,000Source | 29,915,000Source | 29,077,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 3,969,000Source | 4,197,000Source | 667,000Source | 1,714,000Source |
| Other Liabilities, NoncurrentUSD | 88,736,000Source | 73,630,000Source | 63,861,000Source | 80,220,000Source | 68,577,000Source | 65,317,000Source | 79,186,000Source | 64,200,000Source | 91,527,000Source | 79,310,000Source | 63,106,000Source | 60,347,000Source |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | — | — | — | — | — | — | — | 238,794,000Source | 227,983,000Source | 169,452,000Source | 163,479,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — | — | — | — | — | — | — | —Source | —Source |
| Long-term Debt, Current MaturitiesUSD | 22,831,000Source | 16,250,000Source | — | 20,638,000Source | 16,250,000Source | 26,045,000Source | 18,444,000Source | 7,500,000Source | — | — | 29,795,000Source | 22,295,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 597,685,000Source | 619,157,000Source | 291,008,000Source | 603,602,000Source | 622,880,000Source | 297,853,000Source | 609,518,000Source | 287,668,000Source | — | — | 282,289,000Source | 311,541,000Source |
| Short-term InvestmentsUSD | 22,522,000Source | 10,000,000Source | 48,523,000Source | 19,022,000Source | 0Source | 59,523,000Source | 12,504,000Source | 38,000,000Source | 20,575,000Source | 9,000,000Source | 44,000,000Source | 40,000,000Source |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | 26,527,000Source | 6,975,000Source | 99,720,000Source | 48,264,000Source | 2,416,000Source | 32,606,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 12,448,000Source | 12,616,000Source | 12,891,000Source | 11,574,000Source | 12,830,000Source | 9,004,000Source | 51,514,000Source | 45,605,000Source | 36,178,000Source | 34,012,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 339,000Source | 179,000Source | 1,597,000Source | 717,000Source | 475,000Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -11,366,000Source | -9,208,000Source | 7,493,000Source | 55,208,000Source | 8,678,000Source | -5,335,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 26,181,000Source | 5,164,000Source | 86,338,000Source | 44,294,000Source | -2,641,000Source | 11,222,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -4,627,000Source | 1,304,000Source | -12,463,000Source | 45,555,000Source | 12,000,000Source | -22,830,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 7,226,000Source | -4,753,000Source | -11,995,000Source | -2,896,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 9,302,000Source | 12,622,000Source | 68,954,000Source | 80,124,000Source | 87,594,000Source | 13,310,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | 286,529,000Source | 3,282,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -21,014,000Source | -2,930,000Source | -71,455,000Source | -288,688,000Source | -48,194,000Source | -74,018,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | 3,704,000Source | -653,000Source | 792,000Source | -1,134,000Source | -326,000Source | -776,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 16,335,000Source | -29,197,000Source | -6,560,000Source | 207,134,000Source | -6,768,000Source | 26,987,000Source |
| Payments of Ordinary Dividends, Common StockUSD | — | — | — | — | — | — | 4,864,000Source | 4,860,000Source | 19,463,000Source | 19,449,000Source | 19,442,000Source | 19,442,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 4,730,000Source | -18,776,000Source | -6,620,000Source | -2,574,000Source | 29,332,000Source | -32,967,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 54,929,000Source | 60,354,000Source | 55,486,000Source | 67,074,000Source | 72,769,000Source | 51,837,000Source | 61,419,000Source | 68,039,000Source | 70,613,000Source | 41,281,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 42,112,000Source | 32,073,000Source | 17,253,000Source | 14,575,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 20,623,000Source | 13,400,000Source | 15,430,000Source | 20,410,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 107,000Source | 729,000Source | 2,441,000Source | -1,144,000Source | -3,300,000Source | 754,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Debt Issuance CostsUSD | — | — | 572,000Source | 572,000Source | 572,000Source | 504,000Source | 572,000Source | 367,000Source | 2,317,000Source | 2,015,000Source | 1,040,000Source | 727,000Source |
| Amortization of Intangible AssetsUSD | — | — | 1,722,000Source | 1,719,000Source | 1,713,000Source | 2,165,000Source | 1,709,000Source | 2,262,000Source | 6,879,000Source | 7,843,000Source | 9,661,000Source | 9,696,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 1,421,000Source | 1,436,000Source | 1,455,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | — | — | — | — | — | — | — | -10,674,000Source | — |
| DepreciationUSD | — | — | 10,726,000Source | 10,897,000Source | 11,178,000Source | 9,409,000Source | 11,121,000Source | 6,742,000Source | 44,635,000Source | 37,762,000Source | 26,517,000Source | 24,316,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -1,909,000Source | 5,528,000Source | -2,145,000Source | -11,699,000Source | -2,934,000Source | -438,000Source | -12,621,000Source | -7,870,000Source | -23,863,000Source | -2,455,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | — | — | — | 239,000Source | 517,000Source | -1,633,000Source | -600,000Source | -13,114,000Source | 10,398,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | 1,546,000Source | — | 1,257,000Source | 3,786,000Source | — | 3,563,000Source | 2,880,000Source | 899,000Source | — |
| GoodwillUSD | — | — | 59,889,000Source | 54,570,000Source | 59,814,000Source | 54,549,000Source | 59,708,000Source | 54,588,000Source | 60,045,000Source | 59,645,000Source | 54,557,000Source | 53,274,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | — | 885,000,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 8,289,000Source | 8,808,000Source | 8,966,000Source | 1,653,000Source | 9,740,000Source | 2,645,000Source | 37,626,000Source | 19,729,000Source | 8,500,000Source | 21,465,000Source |
| InterestExpenseNonoperatingUSD | — | — | 10,681,000Source | 9,653,000Source | 12,481,000Source | 9,778,000Source | 12,543,000Source | 8,765,000Source | 46,416,000Source | 37,224,000Source | 23,010,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 24,024,000Source | 20,880,000Source | 27,459,000Source | 3,185,000Source | 26,527,000Source | 6,975,000Source | 99,720,000Source | 48,264,000Source | 2,416,000Source | 32,606,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 24,024,000Source | 20,880,000Source | 27,459,000Source | 3,185,000Source | 26,527,000Source | 6,975,000Source | 99,720,000Source | 48,264,000Source | 2,416,000Source | 32,606,000Source |
| Pension Expense (Reversal of Expense), NoncashUSD | — | — | — | — | — | — | — | — | — | — | 10,674,000Source | — |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 383,543,000Source | 347,825,000Source | 373,910,000Source | 309,261,000Source | 363,893,000Source | 260,432,000Source | 1,518,093,000Source | 1,296,215,000Source | 1,017,679,000Source | 977,889,000Source |
| Cost of RevenueUSD | — | — | 257,868,000Source | 243,257,000Source | 241,254,000Source | 207,391,000Source | 244,110,000Source | 176,937,000Source | 1,005,578,000Source | 896,273,000Source | 704,587,000Source | 679,652,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 81,022,000Source | 71,053,000Source | 82,330,000Source | 76,337,000Source | 68,523,000Source | 65,796,000Source | 318,119,000Source | 289,477,000Source | 259,777,000Source | 226,390,000Source |
| Operating Income (Loss)USD | — | — | 44,653,000Source | 33,515,000Source | 50,326,000Source | 25,533,000Source | 51,260,000Source | 17,699,000Source | 194,396,000Source | 110,465,000Source | 53,315,000Source | 71,847,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 32,313,000Source | 29,688,000Source | 36,425,000Source | 4,838,000Source | 36,267,000Source | 9,620,000Source | 137,346,000Source | 67,993,000Source | 10,916,000Source | 54,071,000Source |
| Income Tax Expense (Benefit)USD | — | — | 8,289,000Source | 8,808,000Source | 8,966,000Source | 1,653,000Source | 9,740,000Source | 2,645,000Source | 37,626,000Source | 19,729,000Source | 8,500,000Source | 21,465,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 24,024,000Source | 20,880,000Source | 27,459,000Source | 3,185,000Source | 26,527,000Source | 6,975,000Source | 99,720,000Source | 48,264,000Source | 2,416,000Source | 32,606,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.59Source | 0.52Source | 0.68Source | 0.08Source | 0.65Source | 0.17Source | 2.46Source | 1.19Source | 0.06Source | 0.81Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.59Source | 0.51Source | 0.67Source | 0.08Source | 0.65Source | 0.17Source | 2.43Source | 1.19Source | 0.06Source | 0.81Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 40,551,000Source | 40,520,000Source | 40,534,000Source | 40,504,000Source | 40,534,000Source | 40,504,000Source | 40,546,000Source | 40,515,000Source | 40,504,000Source | 40,504,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 41,037,000Source | 40,709,000Source | 40,956,000Source | 40,715,000Source | 40,877,000Source | 40,582,000Source | 40,964,000Source | 40,678,000Source | 40,523,000Source | 40,504,000Source |
| Interest Expense (non-operating)USD | — | — | 10,681,000Source | 9,653,000Source | 12,481,000Source | 9,778,000Source | 12,543,000Source | 8,765,000Source | 46,416,000Source | 37,224,000Source | 23,010,000Source | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 1,722,000Source | 1,719,000Source | 1,713,000Source | 2,165,000Source | 1,709,000Source | 2,262,000Source | 6,879,000Source | 7,843,000Source | 9,661,000Source | 9,696,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | 130,000Source | 636,000Source | 193,000Source | 8,815,000Source | 258,000Source | 3,424,000Source | 1,305,000Source | — | — | — |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 1,421,000Source | 1,436,000Source | 1,455,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | 0.12Source | 0.12Source | 0.12Source | 0.12Source | 0.12Source | 0.12Source | 0.48Source | 0.48Source | 0.48Source | 0.48Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 30,400,000Source | 24,482,000Source | 20,495,000Source | 24,361,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | — | — | — | — | — | — | — | -10,674,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -1,909,000Source | 5,528,000Source | -2,145,000Source | -11,699,000Source | -2,934,000Source | -438,000Source | -12,621,000Source | -7,870,000Source | -23,863,000Source | -2,455,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | 1,546,000Source | — | 1,257,000Source | 3,786,000Source | — | 3,563,000Source | 2,880,000Source | 899,000Source | — |
| Gross ProfitUSD | — | — | 125,675,000Source | 104,568,000Source | 132,656,000Source | 101,870,000Source | 119,783,000Source | 83,495,000Source | 512,515,000Source | 399,942,000Source | 313,092,000Source | 298,237,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 57,480,000Source | 3,304,000Source | -22,820,000Source | 14,776,000Source |
| Interest and Other IncomeUSD | — | — | 250,000Source | 298,000Source | 725,000Source | 782,000Source | 484,000Source | 1,124,000Source | 1,987,000Source | 2,622,000Source | 4,474,000Source | 3,355,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 18,676,000Source |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | — | — | -15,321,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | -10,431,000Source | -9,355,000Source | -11,756,000Source | -8,996,000Source | -12,059,000Source | -7,641,000Source | -44,429,000Source | -34,602,000Source | -18,536,000Source | -15,321,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 24,024,000Source | 20,880,000Source | 27,459,000Source | 3,185,000Source | 26,527,000Source | 6,975,000Source | 99,720,000Source | 48,264,000Source | 2,416,000Source | 32,606,000Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | 24,551,000Source | 23,726,000Source | 29,194,000Source | 24,395,000Source |
Filing attachments
pahc-ex99d1.htm · 8-K · 2026-11-04
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance TEANECK, N.J., November 4, 2026 (Business Wire) - Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2026 and maintained its financial guidance for the year ending June 30, 2027. Highlights for the three months ended September 30, 2026 (compared to the three months e…
Read attachment ↗tm2628782d1_ex99-1.htm · 8-K · 2026-11-03
Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., November 3, 2026 (Business Wire) - The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026, to stockholders of record at the close of business on November 25, 2026. About Phibro Animal Health Corporation Phibro Animal Health…
Read attachment ↗pahc-20260826xex99d1.htm · 8-K · 2026-08-26
EX-99.1 2 pahc-20260826xex99d1.htm EX-99.1 Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance TEANECK, N.J., August 26, 2026 (Business Wire) - Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial guidance for the fiscal year ending June 30, 2027. Highlight…
Read attachment ↗tm2621206d1_ex99-1.htm · 8-K · 2026-07-28
EX-99.1 2 tm2621206d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., July 28, 2026 (Business Wire) - The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026. About Phibro…
Read attachment ↗pahc-20260506xex99d1.htm · 8-K · 2026-05-06
EX-99.1 2 pahc-20260506xex99d1.htm EX-99.1 Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance TEANECK, N.J., May 6, 2026 (Business Wire) - Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2026, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended March 31, 2026 (…
Read attachment ↗tm2613490d1_ex99-1.htm · 8-K · 2026-05-05
EX-99.1 2 tm2613490d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J., May 5, 2026 (Business Wire) - The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to stockholders of record at the close of business on June 3, 2026. About Phibro Animal Heal…
Read attachment ↗